# BioAtla, Inc.: Form 8-K, filed Oct 20, 2026

- Company: [BioAtla, Inc.](/companies/bcab.md) (CIK 1826892)
- Form: 8-K
- Filed: 2026-10-20
- Accepted by EDGAR: Oct 19, 2026, 21:33 ET
- Period: 2026-10-15
- Accession: 0001193125-26-425553
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1826892/000119312526425553/bcab-20261015.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1826892/000119312526425553/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1826892/000119312526425553/bcab-20261015.htm

Filed Oct 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-425553. Last ingested by Listed: Oct 30, 2026, 06:15 ET. No prices; not investment advice.
